EMPRESSION Trademark

Trademark Overview


On Thursday, July 9, 2020, a trademark application was filed for EMPRESSION with the United States Patent and Trademark Office. The USPTO has given the EMPRESSION trademark a serial number of 90043769. The federal status of this trademark filing is REGISTERED as of Tuesday, November 30, 2021. This trademark is owned by Empress Therapeutics, Inc.. The EMPRESSION trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific research, pharmaceutical research, medical research; technical scientific consultation and product development for others in the field of biotechnology and the development of pharmaceuticals and microbial products; research and development in the field of computational biology, bioinformatics, genomics, biotechnology, pharmaceuticals, and microbial products; Platform as a service (PAAS) featuring computer software platforms for research and development in the field of computational biology, bioinformatics, genomics, biotechnology, pharmaceuticals, and microbial products
empression

General Information


Serial Number90043769
Word MarkEMPRESSION
Filing DateThursday, July 9, 2020
Status700 - REGISTERED
Status DateTuesday, November 30, 2021
Registration Number6577540
Registration DateTuesday, November 30, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 24, 2020

Trademark Statements


Pseudo MarkIMPRESSION
Goods and ServicesScientific research, pharmaceutical research, medical research; technical scientific consultation and product development for others in the field of biotechnology and the development of pharmaceuticals and microbial products; research and development in the field of computational biology, bioinformatics, genomics, biotechnology, pharmaceuticals, and microbial products; Platform as a service (PAAS) featuring computer software platforms for research and development in the field of computational biology, bioinformatics, genomics, biotechnology, pharmaceuticals, and microbial products

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, August 12, 2020
Primary Code042
First Use Anywhere DateThursday, December 31, 2020
First Use In Commerce DateThursday, December 31, 2020

Trademark Owner History


Party NameEmpress Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Party NameEmpress Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Party NameEmpress Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events


Event DateEvent Description
Tuesday, November 30, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, October 26, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, October 25, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, October 15, 2021ASSIGNED TO EXAMINER
Saturday, August 28, 2021STATEMENT OF USE PROCESSING COMPLETE
Thursday, August 26, 2021USE AMENDMENT FILED
Saturday, August 28, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, August 26, 2021TEAS STATEMENT OF USE RECEIVED
Wednesday, July 21, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 19, 2021SOU EXTENSION 1 GRANTED
Monday, July 19, 2021SOU EXTENSION 1 FILED
Monday, July 19, 2021TEAS EXTENSION RECEIVED
Tuesday, January 19, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 24, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 24, 2020PUBLISHED FOR OPPOSITION
Wednesday, November 4, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 20, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 20, 2020ASSIGNED TO EXAMINER
Wednesday, August 12, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM